DSpace at RU >
University Library >
Academic bibliography >
|Title: ||Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment.|
|Author(s): ||Guery, B.P.|
Borges Sa, M.
Zaragoza Crespo, R.
Kullberg, B.J. (074528858)
|Publication year: ||2009|
|Document type: ||Article / Letter to editor|
|Journal: ||Intensive Care Medicine|
|Volume: ||vol. 35|
|Issue: ||iss. 2|
|Start page: ||p. 206|
|End page: ||p. 214|
|Abstract: ||BACKGROUND: Invasive candidiasis and candidemia are frequently encountered in the nosocomial setting particularly in the intensive care unit (ICU). OBJECTIVE AND METHODS: To review the current management of invasive candidiasis and candidemia in non-neutropenic adult ICU patients based on a review of the literature and an European expert panel discussion. RESULTS AND CONCLUSIONS: Empiric and directed treatment for invasive candidiasis are predicated on the hemodynamic status of the patient. Unstable patients may benefit from broad-spectrum antifungal agents, which can be narrowed once the patient has stabilized and the identity of the infecting species is established. In stable patients, a more classical approach using fluconazole may be satisfactory provided that the patient is not colonized with fluconazole resistant strains or there has been recent past exposure to an azole (<30 days). In contrast, pre-emptive therapy is based on the presence of surrogate markers.|
|Subject: ||N4i 2: Invasive mycoses and compromised host|
|Organization: ||General Internal Medicine|
|Appears in Collections:||Academic bibliography|
Please use this identifier to cite or link to this item:
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.